MoonLake Immunotherapeutics (NAS:MLTX)
$ 53.71 0.6 (1.13%) Market Cap: 3.38 Bil Enterprise Value: 2.82 Bil PE Ratio: 0 PB Ratio: 6.40 GF Score: 22/100